Losartan Potassium tablets recalled for manufacturing impurity above limits
Lupin Pharmaceuticals is recalling Losartan Potassium Tablets 100 mg nationwide due to AZIDO impurity levels exceeding acceptable manufacturing limits. Approximately 1,247,067 bottles were affected.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a prescription medication without reported illnesses or hospitalizations. The hazard is a manufacturing quality issue (AZIDO impurity above limits) representing a risk of harm, but no actual injuries have been documented.
Plain-English summary
Lupin Pharmaceuticals Inc. is recalling Losartan Potassium Tablets USP, 100 mg, due to Current Good Manufacturing Practice (CGMP) deviations. Testing identified AZIDO impurity levels in affected batches that exceed acceptable manufacturing limits.
The recall covers approximately 1,247,067 bottles distributed nationwide in both 90-count and 1,000-count package sizes, with expiration dates ranging from October 2022 through March 2023. Affected bottles are identified by lot codes including H903573, H002311, H100713, and others with corresponding expiration dates.
Patients currently taking affected tablets should contact their pharmacist or healthcare provider to verify their medication is included in this recall and discuss any appropriate next steps or alternative medications.
The recalled product
- Product
- LOSARTAN POTASSIUM (LOSARTAN POTASSIUM)
- Brand
- LOSARTAN POTASSIUM
- Manufacturer
- Lupin Pharmaceuticals Inc.
- Category
- Drug
- Hazard
- manufacturing-defect
- azido-impurity
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- H903573
- exp. date Oct-22 H002311
- exp. date Dec-22 H100713
- exp. date Mar-23 H001060
- exp. date Nov-22 H002620
- exp. date Jan-23 H100714
- exp. date Mar-23 H001456
- exp. date Nov-22 H002313
- exp. date Jan-23 H100934
- exp. date Mar-23 H001457
- exp. date Nov-22 H002490
- exp. date Jan-23 H100935
- exp. date Mar-23 H001470
- exp. date Nov-22 H002842
- exp. date Jan-23 H101081
- exp. date Mar-23 H001484
- exp. date Dec-22 H002843
- exp. date Jan-23 H101148
- exp. date Mar-23 H001485
- exp. date Dec-22 H002995
UPCs (9)
- 0368180212065
- 0368180376033
- 0368180210061
- 0368180378037
- 0368180308027
- 0368180376095
- 0368180211068
- 0368180309024
- 0368180377030
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · LOSARTAN POTASSIUM
- HighLosartan Potassium Tablets Recalled for Blue Plastic Contamination
FDA (Drugs) · 2023-07-12
- HighLosartan Potassium Tablets Recalled for Elevated AZIDO Impurity Levels
FDA (Drugs) · 2022-07-06
- HighLosartan Potassium tablets recalled for elevated AZIDO impurity
FDA (Drugs) · 2022-07-06
- HighLosartan Potassium Tablets Recalled for Manufacturing Impurity Issues
FDA (Drugs) · 2022-07-06
- ModerateLosartan Potassium tablets recalled for excessive AZIDO impurity
FDA (Drugs) · 2022-06-08
Same category
- SevereChloraPrep One-Step Applicators Recalled for Potential Packaging Seal Defects
FDA (Drugs) · 2026-07-22
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateMeijer Earwax Removal Kit Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2026-07-22